Increasing Prevalence of Chronic Diseases to Augment the Smart Home Medical Device Market Growth

 

Smart medical devices are the application of Internet-of-Things (IoT) in healthcare. These devices alleviate many of the problems hindering the delivery of good healthcare to people worldwide. Apart from smart home medical devices, smart healthcare devices also add quality and longevity to human life.

 

Moreover, a smart home medical device connects doctors with patients at home or in route to the hospital. These devices provide patients with a high degree of mobility and healthcare providers with the ability to monitor patient status remotely.

Market Dynamics:

Increasing prevalence of chronic diseases, such as cancer, diabetes, heart disease, etc., and the growing geriatric population worldwide is expected to propel the growth of the smart home medical device market. For instance, For instance, according to the World Health Organization (WHO), cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018.

Moreover, growing popularity of Internet-of-Things in home healthcare, increasing demand for personalized healthcare in developed countries, and technological advancements are expected to augment the growth of the smart home medical device market.

Increasing partnerships and collaborations between major players are also expected to fuel the growth of the smart home medical device market. For instance, in January 2021, and Spencer Health Solutions and Otsuka Pharmaceutical Development and Commercialization jointly created a transformational patient experience using the spencer smart hub, the world’s first at-home medication device that connects patients and their care teams through an easy-to-use, fully integrated platform.

However, high cost of smart home medical devices, stringent regulations, and concerns regarding data privacy and security are expected to restrain growth of the smart home medical device market.

North America is expected to witness robust growth in the smart home medical device market due to the increasing prevalence of chronic diseases in the region. For instance, chronic diseases such as diabetes, cancer, and heart disease are the leading causes of death and disability in the U.S., according to the Centers for Disease Control and Prevention (CDC).

Competitive Analysis:

Major players operating in the smart home medical device market are Neurometrix, Qardio, Cyrcadia Health, Proteus Digital Health, VitalConnect, Hocoma AG, Health Care Originals, and ViVO Smart Medical Devices Ltd.

Major players in the market are adopting various business strategies such as product launches, to strengthen their product portfolio. For instance, in January 2021, ICON.AI launched World's first smart healthcare device at CES 2021 (Consumer Electronics Show). The two-in-one smart healthcare device helps identify physiological abnormalities.

Global Special Needs Strollers Market is Expanding Rapidly with Industry Leader Convaid Inc. Introducing new stroller R82 x: Panda

 

A parent may wish the convenience of being able to place their child securely in a special needs strollers, even as they grow older, yet as they get older, an adult may wish their own child to learn independent, self-reliant habits. For smaller kids, it might be easier to push a stroller instead of trying to do so in a seat. As your child gets older and bigger, the task can become more challenging. However, there are many options available that allow you to place your child securely in the strollers or push them along on foot. It is important that you take time to consider how your child will handle this. 

 

Increasing prevalence of neurodegenerative disorders in children is expected to drive growth of the global special needs strollers market. A high number of children suffer from different types of neurodegenerative disorders including cerebral palsy, spinal muscular atrophy (SMA), etc. According to the study, ‘Carrier frequency of SMN1-related spinal muscular atrophy in north Indian population: The need for population-based screening program’ published in American Journal of Medical Genetics, in October 2020, the carrier frequency of Spinal Muscular Atrophy (SMN) 1 deletion was 1 in 38 (16 out of 606). SPA is characterized by weakness and wasting i.e. atrophy in muscles used for movement of skeletal muscles. It is typically caused by the loss of specialized nerve cells, called motor neurons. Such children require assistive strollers for overall movements. Hence, such factors are expected to drive growth of the global special needs strollers market. Furthermore, technical advancements in strollers are expected to propel growth of the global special needs stroller needs market.

However, high cost associated with strollers is expected to restrain growth of the global special needs strollers market in the near future. Among regions, North America is expected to witness significant growth in the global special needs strollers market. This is owing to high rate of adoption of towards latest technologies and proactive government support. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to rising government funding and support programs for children with physical and mental impairment.

Key companies involved in the global special needs strollers market are Convaid Inc., Ottobock, Deming Designs, Inc., Special Tomato (Bergeron Health Care), Thomashilfen.us, Meyra, Eurovema Ab, Invacare Corporation, Adaptive Star, Ormesa, and Sunrise Medical LLC

For instance, in January 2019, Convaid Inc., a subsidiary of Etac AB, introduced a new stroller R82 x: Panda.

High Prevalence of Neurological Diseases and Increasing Geriatric Population to Augment Growth of Tardive Dyskinesia Drugs Market

 

Tardive dyskinesia is a rare involuntary, often mute, motor neural disease caused by the excessive use of dopamine antagonist drugs that are usually prescribed to treat some psychiatric or gastrointestinal disorders. Long term use of such drugs can produce severe biochemical changes in the brain's reward system, the part of the brain which is involved in coordinating behavior with the actions of the body. The main causes that some of those who take such drugs might acquire tardive dyskinesia is unknown, but the main reasons that others don't is still unknown.

 

Market Dynamics

High prevalence of neurological diseases is expected to propel growth of the tardive dyskinesia drugs market. For instance, according to the World Health Organization (WHO), the percentage of total disability-adjusted life years (DALYs) of epilepsy is expected to account for 0.5% while of cerebrovascular diseases for 3.6%. Moreover, percentage of total DALYs of cerebrovascular disease is projected to reach 3.9%, while that of epilepsy is expected to remain more or less constant by 2030. Moreover, high prevalence of tardive dyskinesia is also expected to aid in growth of the market. The average prevalence of tardive dyskinesia is estimated to be at least 20% of all patients who were treated with first-generation neuroleptics.

Increasing geriatric population is expected to offer lucrative growth opportunities for players in the tardive dyskinesia drugs market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Moreover, increasing sales of tardive dyskinesia drugs is also expected to aid in growth of the market. For instance, in January 2021, Neurocrine Biosciences, Inc. reported that full-year 2020 total INGREZZA (INGREZZA is a selective vesicular monoamine transporter 2 inhibitor indicated for the treatment of adults with tardive dyskinesia) prescriptions grew 32% to approximately 175,700 versus 2019 total prescriptions of approximately 132,700.

Competitive Analysis

Major players operating in the tardive dyskinesia drugs market include, Valeant Pharmaceuticals, Neurocrine Biosciences, and Teva Pharmaceutical Industries.

Major players operating in the tardive dyskinesia drugs market are focused on adopting various strategies to enhance their market share. For instance, in September 2020, Neurocrine Biosciences, Inc. announced to present new data as part of 30 abstracts accepted from its movement disorder programs for tardive dyskinesia and Parkinson's disease at the virtual scientific meetings, 2020 Psych Congress and the MDS Virtual Congress 2020.

In-depth Report on Tardive Dyskinesia Drugs Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/ongoing-insight/tardive-dyskinesia-drugs-market-218

Increasing Prevalence of Asthma and Emergence of Covid-19 to Augment Growth of Respiratory Inhalers Market

 

Respiratory inhalers can be classified into various types according to their mechanism of action and usage. They are broadly classified into two categories as therapeutic and prophylactic, based on their chemical structure and mechanism of action. Therapeutic Respiratory Inhalers are used for treating acute respiratory conditions such as allergies, asthma, COPD, rhinitis, sinusitis, viral respiratory infection, pneumonia, irritations of the respiratory tract caused due to exposure to dust and other airborne irritants, including pollens, molds, and animal dander, inhalers for preventing short-term complications of respiratory disease. They are also used to control chronic obstructive pulmonary disease (COPD) in people with emphysema. Respiratory prophylactics are used for preventing or controlling complications of diseases that are associated with obstruction of the respiratory tract, such as tuberculosis, bronchitis, pneumonia, and emphysema.

Market Dynamics

Increasing prevalence of asthma is expected to propel growth of the global respiratory inhalers market. For instance, According to The Global Asthma Report 2018, around 300 million people have asthma worldwide, and the number is expected to reach 100 million by 2025. Moreover, initiatives to boost adoption of dry powder inhalers is also expected to aid in growth of the market. For instance, in September 2018, researchers from University of Helsinki, Finland, reported investigation of non-verbal, demonstrational videos as a method of teaching inhaler naïve individuals how to use a dry powder inhaler.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global respiratory inhalers market. For instance, globally, as of 4:35pm CET, 27 January 2021, there have been 99,864,391 confirmed cases of COVID-19, including 2,149,700 deaths, reported to the World Health Organization. Moreover, launch of solutions to track usage pattern of metered-dose inhalers is also expected to aid in growth of the market. For instance, in November 2019, Lupin Ltd. launched a device – Adhero – to track usage pattern of metered-dose inhalers (MDI) by patients suffering from chronic respiratory diseases.

Competitive Analysis

Major players operating in the global respiratory inhalers market include, AstraZeneca plc., Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc., Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding, and Teva Pharmaceutical Industries Ltd.

Major players operating in the global respiratory inhalers market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2019, Glenmark Pharmaceuticals launched two new steroid inhalers that include Soprobec (beclometasone), a metered-dose aerosol inhaler, and Stalpex (salmeterol/fluticasone), a breath-actuated inhaler. Similarly, in April 2019, Cipla Ltd. launched Niveoli, an extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, which can be used for the treatment of asthma and COPD.

In-depth Report on Respiratory Inhalers Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/market-insight/respiratory-inhalers-market-227

Increase in Cases of Neuroendocrine Tumors to Augment the Neuroendocrine Tumors Treatment Market Growth

 

Neuroendocrine tumors arise from cells of the endocrine and nervous systems. Neuroendocrine tumors are cancers that begin in specialized cells called neuroendocrine cells. They are commonly found in the intestine, where they are often called carcinoid tumors, but they are also found in the lungs, pancreas, and the rest of the body.

However, neuroendocrine tumors treatment entirely depends on the type of the tumor. Some approaches may include surgery, radiation and chemotherapy. A neuroendocrine tumor can grow slowly or aggressively and spread to other parts of the body. Many people do not develop symptoms and tumors are detected incidentally.

Market Dynamics:

Increasing prevalence of neuroendocrine tumors, especially in North America, is expected to propel the growth of the neuroendocrine tumors treatment market. For instance, according to the American Society of Clinical Oncology (2019), each year, more than 12,000 people in the U.S. are diagnosed with a neuroendocrine tumors. The number of people diagnosed with this type of tumor has been increasing for years.

Moreover, increasing number of drug approvals for the treatment of neuroendocrine tumors is expected to fuel the growth of the neuroendocrine tumors treatment market. For instance, in December 2020, Hutchison China MediTech Limited received the National Medical Products Administration of China (NMPA) approval for surufatinib for the treatment of non-pancreatic neuroendocrine tumors.

Increase in government initiatives and funding by various international organizations is also expected to augment the growth of the neuroendocrine tumors treatment market. For instance, in February 2020, the Neuroendocrine Tumor Research Foundation announced US$ 3.5 million in neuroendocrine tumor research grants to fund 12 projects around the world in pursuit of more precise treatments for this uncommon cancer.

Furthermore, government initiatives for cancer awareness, the growing patient assistance programs, and extensive research and development by pharmaceutical companies are expected to drive the neuroendocrine tumors treatment market growth.

However, side effects associated with the treatment and the high cost of drug or therapy development are expected to restrain the market growth. Development of gallstones, high blood sugar, and mild digestive system upset such as nausea and bloating are some of the possible side effects associated with neuroendocrine tumor treatments.

Competitive Analysis:

Major players operating in the neuroendocrine tumors treatment market are Exelixis, Dauntless Pharmaceuticals Inc., Hutchison Medipharma Limited, Progenics Pharmaceuticals, Tarveda Therapeutics, Advanced Accelerator Applications, Ispen, Novartis AG, and Pfizer Inc.

In 2018, Novartis received the United States Food and Drug Administration (FDA) approval for Lutathera for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors.

Increasing Prevalence of Hearing Impairment (Loss) to Augment the Electronic Hearing Protection Device Market Growth

 

An electronic hearing protection device is an ear protecting device worn either over the original earrings or on the inner ear when exposed to loud noise. The term 'Hearing Protection Device' is used to generally describe any type of protective Ear Protectors, whether made of metal, foam, plastic, or some type of neoprene appliance. These protectors are very useful for people working in industrial environments, factories, power facilities, ships, trains, stadiums, etc. 

 

There are several types of hearing protection devices such as earmuffs, earplugs, hearing bands, and others. Earplugs are devices inserted in the ear canal to protect the ear from excessive wind, dust, foreign bodies, water intrusion, or loud noise, while earmuffs can be used at war (defense sector), music concerts, mines, and manufacturing sites to provide protection by reducing noise levels.

Market Dynamics:

Increasing prevalence of noise-induced hearing loss (hearing impairment) is expected to propel the growth of the electronic hearing protection device market. For instance, according to the Centers for Disease Control and Prevention (CDC), 5.2 million children and adolescents aged 6 to 19 years 26 million adults aged 20 to 69 years have suffered permanent damage to their hearing from excessive exposure to noise. Noise-induced hearing loss is a slow process that results in permanent hearing loss.

Moreover, increasing noise pollution and exposure to intense noise is also expected to fuel the growth of the electronic hearing protection device market. Elevated sound levels that may lead to adverse effects in humans or other living organisms.

However, lack of awareness among people about hearing protection devices is expected to restrain the growth of the electronic hearing protection device market.

North America is expected to witness substantial growth in the market due to the increasing prevalence of hearing loss in the region. According to World Health Organization, in March 2019, one out of every ten people in the United States suffer from hearing impairment.

Competitive Analysis:

Major players operating in the electronic hearing protection device market are EERS Global Technologies Inc., ADCO Hearing Products Inc., 3M, Centurion Safety Products Ltd., Hulfators Group, Dynamic Ear Company, Siemens Healthineers AG, Amplifon, and Honeywell International Inc.

Major players in the market are adopting various business strategies such as product launches, to strengthen their product portfolio. For instance, in February 2020, GTX Corp announced the launch of a new patented wearable technology noise reduction system designed to protect the wearer from loud background noises, without interfering or drowning out direct verbal communication. Perfect for people with autism, motorcycle riders, race car drivers, oil and gas workers, recreational firearms users, hunters, first responders, law enforcement, and defence/military.

Global Custom LASIK Surgery Market Continues to Expands as Johnson & Johnson receives the U.S. FDA approval for its new laser eye surgery named iDesign Refractive Studio system

 

LASIK is short for Laser-Assisted In Situ Keratomileusis, and is a type of cosmetic surgery for the treatment of myopia, hyperopic, and astigmatism, commonly known as refractive eye correction. The procedure uses a laser to reshape the cornea and thus correct the vision. This procedure has been approved by the FDA in 1998. It is a minimally invasive procedure that offers many patient benefits, including the ability to wear contacts and glasses in an effort to correct vision problems. The majority of LASIK surgical procedures are performed on an outpatient basis at an eye clinic, although some patients may require hospitalization if their eyes become infected.

 

Increasing incidence of refractive disorders is expected to drive growth of the global custom LASIK surgery market. According to the American Academy of Ophthalmology, in 2016, around 23% of the U.S. population aged 40 years and above was suffering from myopia. According to the World Health Organization (WHO), by 2020, around 2.56 billion people are to get affected by myopia. LASIK surgery reshapes the cornea with an excimer laser and is done with a computer-controlled excimer cold laser. Besides, it also uses a microkeratome for these types of surgeries. Furthermore, custom LASIK surgery has greater accuracy than conventional LASIK surgery since it uses wavefront technology to create a highly-detailed 3D map of the cornea. Hence, such factors are expected to drive growth of the global custom LASIK surgery market. Furthermore, technological advancements in LASIK surgeries are expected to propel the global custom LASIK surgery market growth in the near future.

However, high cost of treatment and complexity in technology is expected to restrain growth of the global custom LASIK surgery market. Among regions, North America is expected to witness significant growth in the global custom LASIK surgery market. This is owing to increasing demand for effective therapeutic treatment options for eye disorders. Furthermore, increasing product approvals by regulatory authorities are expected to boost the regional market growth in the near future. Asia Pacific is expected to register a robust growth rate, owing to rising patient awareness regarding the benefits of LASIK surgery and improvement in healthcare infrastructure in the region.

Key players operating in the global custom LASIK surgery market are Johnson & Johnson, Ziemer Group AG (Ziemer Ophthalmic Systems), Alcon Inc., Nidek Co. Ltd., Bausch Health Companies Inc., Lasersight Technologies, Inc., Bausch Health Companies Inc., and Carl Zeiss AG.

For instance, in October 2019, Johnson & Johnson received the U.S. Food and Drug Administration (FDA) approval for its new laser eye surgery named iDesign Refractive Studio system.

Advancement in the production of household detergent to increase market size of linear alkylbenzene sulfonate (LAS)

 

Linear alkylbenzene sulfonate (LAS) is one of the most popular synthetic surfactants which is prepared by sulfonating linear alkylbenzene (LAB). This product is a petrochemical derivative and it is majorly used in the production of detergent as well as various industrial cleaners’ products. Dish washing liquids, industrial cleaners, personal care products, and household detergents & cleaners are some of the major application areas of the linear alkylbenzene sulfonate (LAS).

Increasing demand for linear alkylbenzene sulfonate (LAS) from household detergent is propelling the market growth. Growing hygiene awareness coupled with the advancement in the production of detergent is again expected to accelerate the market growth. Also, the integration of AI in IoT in washing machines is contributing to the industrial expansion. Ongoing research and development activities in the field of high-efficient laundry detergent is again projected to propel the market growth of linear alkylbenzene sulfonate (LAS). Increasing demand for dishwashing liquids along with the growing popularity of personal care products such as shampoo, creams, lotions, shower gels, and hair conditioners are further estimated to uplift the market growth in the near future.

In addition to this, the high demand for cleaners from various industries is projected to bring new and profitable opportunities for the linear alkylbenzene sulfonate (LAS) market over the forecast period. On the other hand, strict rules and regulation associated with the production and use of linear alkylbenzene sulfonate is expected to hinder the market growth.

From the geographical point of view, the Asia Pacific is expected to exhibit significant growth over the forecast period and this is attributed to the increasing population coupled with the changing lifestyle of the consumers due to growing disposable income. According to the United Nation, the Asia and the Pacific region is home to 4.1 billion people or two-thirds of the world’s population. Also, rapid urbanization and industrialization in the region are further projected to propel the regional market growth of linear alkylbenzene sulfonate (LAS).

Key Developments:

In June 2019, Spanish petrochemicals producer CEPSA has upgraded its chemical plant in Puente Mayorga (Cadiz, Spain), making it the first linear alkyl benzene (LAB) facility in the world to replace hydrofluoric (HF) technology with the Detal process.

Key Players:

BASF SE, Clariant Corporation, Rhodia SA, Hansa Group AG, Croda International, Huntsman Corporation, Henkel AG & Co. KGaA, Evonik Industries AG, Stepan Company, Galaxy Surfactants Ltd., DuPont and The Dow Chemical Company.

Portable Medical Gas Analyzers Offer Various Advantages Over Stand-Alone Type Medical Gas Analyzers

 

Medical gas analyzers are used for the detection, measurement, and analysis of medical gases in hospitals and healthcare industries. In Germany, Ntron Gas Measurement Ltd. is one of the major producers of these analyzers. In November 2019, the company presented its technologies in measurement of oxygen and impurities at FormNext 2019. Many hospitals today use portable analyzers to monitor patient vital signs, body temperatures and even to remotely control air-purifying and humidifiers. These analyzers offer medical professionals the information they need in order to treat patients better. They can also prevent the emergency of life threatening situations. In addition, portable medical gas analyzers allow hospitals to improve their patient care by providing accurate and reliable information whenever possible.

 

Oxygen analyzers measure the amount of oxygen in a particular substance. They may also test for quality and purity. These analyzers are often used to determine the amount of oxygen in the blood stream after serious accidents or other medical procedures. The two main types of medical oxygen analyzers are the portable and the stand-alone type. Portable oxygen analyzers are usually smaller in size and lighter in weight than the stand-alone type oxygen analyzer. These types of analyzers have a number of useful features like auto diagnosis, support for up to four tanks of oxygen, customizable alerts and many more. It is not possible to get all the information you may want from a single monitor in a limited space, especially if you are working with a limited amount of space. It is important to make maximum use of space available.

Another example of a portable medical gas analyzers is the anesthesia monitor. It has a built-in probe for the patient's blood pressure. You can connect it with your PC or an external blood pressure monitor. Many medical professional prefer this particular brand because of the outstanding performance and reliability. Another good example of portable monitor is the teledyne oxygen analyzer. This brand comes in two different models - the Thermo-Exceedingly Waterproof Pressure Pro, which are particularly designed for the health care industry and the Thermo-Max Hydrated Display Pressure System. Both these models have been developed with advanced technology to meet the specific needs of patients. They measure the oxygen saturation level of the blood fast and easily. The asteroid is easy to use and reliable, especially if used in hospitals and other medical facilities.

Sulfacetamide Sodium, Moxifloxacin, Gatifloxacin, Erythromycin, Polymyxin/Trimethoprim, and Bacitracin Are Some of the Most Effective Bacterial Conjunctivitis Drugs

 

Bacterial conjunctivitis is a common type of pink eye, caused by bacteria that infect the eye through various sources of contamination. Eye drops and eye ointments along with bacterial conjunctivitis drugs such as Bleph (sulfacetamide sodium), Moxeza (moxifloxacin), Zymar (gatifloxacin), Romycin (erythromycin), Polytrim (polymyxin/trimethoprim), Ak-Tracin, Bacticin (bacitracin), AK-Poly-Bac, Ocumycin, Polycin-B, Polytracin can provide relief for symptoms. However, they cannot cure the infection that causes these symptoms. This is why it's important to get an accurate diagnosis of the condition before using any type of treatment. And when bacterial conjunctivitis is responsible, a reliable test to confirm it is to be had.

 

The basic test for bacterial conjunctivitis is called the AVR or visual field test. The doctor will have you look at your cornea through a special optical device called an ophthalmoscope. One red eye and one normal color is all that is required. For this test, one drop of azithromycin ointment will be sufficient. Another way to confirm the presence of bacterial conjunctivitis is to perform a blood test. One drop of a solution of Bacitracin or fluconazole is just sufficient. Thickening of the ointment is a good indication of bacterial contamination. A dark red ointment is another indicator. All three tests are done on an individual basis.

Of all the bacterial conjunctivitis drugs, those made with Methylsulfonylmethane (also known as galactic acid) are the best. These products are readily available in drugstores and are relatively inexpensive. A few brands available in the US include, Aclorix, Advion, and Benadryl. The reason why they work so well is because of the low concentration of sulfamethoxazole (the active ingredient). The other ingredients merely act as additives.

Bacterial conjunctivitis can be difficult to treat and is often accompanied by severe red eye and itching, although there are cases where both are absent. Since it affects the eye, an ophthalmology expert must be consulted to determine the cause. Bacterial conjunctivitis drugs also include topical antibiotics and systemic antibiotics. Topical antibiotics are given topically and are given to individuals who experience red eye or itching. They do not enter the blood stream and therefore do not carry any antibiotic resistance patterns in the organism.

Systemic antibiotics are usually administered orally or by mouth. These antibiotics, also available generically, must pass through the digestive tract before being absorbed into the bloodstream. Thus, they may lead to unpleasant side effects like nausea and diarrhea. A broad-spectrum antibiotic is one that is effective against all bacteria and is highly recommended for use in case of bacterial conjunctivitis, since it is able to eliminate all strains. Moxifloxacin and aminoglycosides can provide long-term relief from bacterial conjunctivitis, especially when used in combination. Moxifloxacin works by reducing the ability of odor producers to stick to cell membranes. It decreases the permeability of membranes by preventing bacterial membranes from leaking chemicals or toxins into the adjacent tissues. Moxifloxacin is particularly useful for cases such as contact lens infections, allergic conjunctives, and acute keratitis, while aminoglycosides are useful for patients with diabetes and kidney disease. Azathioprine and mercaptopurine are the most commonly prescribed systemic antibiotics in conjunctivitis treatment. In cases of systemic failure, bacterial conjunctivitis drugs such as sulfasalazine, methotrexate, and heparin may also be prescribed.

Clinical studies have revealed that systemic tobramycin is effective in the treatment of bacterial conjunctivitis and acute stomatitis. Although the clinical trials did not directly correlate the levels of tobramycin with the severity of the symptoms, the drug significantly improved both subjective and objective scores on the EKG and blood test results. Similarly, in a study involving patients with chronic stomatitis, long-term therapy with fluconazole showed significant improvement. The efficiency of long-term topical treatment was associated with the level of resistance of the patient's immune system to tobramycin. Thus, it was concluded that the efficacy of tobramycin for the treatment of bacterial conjunctivitis depends on the degree of resistance of the host organism to the drug.

General Anesthesia Drugs Find Application in Surgical Procedure, Recovery from Surgery, Maintaining Animal Behavior, or For Administering Oral Medications

 

General anesthesia drugs and sedatives are common in veterinary medicine for temporary, chemical restraint, and as an adjunct with surgical procedure. Sedatives and narcotics are administered for a number of reasons, including recovery from surgery, maintaining animal behavior, or for administering oral medications. Sedatives and narcotics can be administered for a variety of purposes, but the most common types of anesthesia used on animals are general anesthesia and barbiturates. General anesthesia or sedative drugs are administered for a number of reasons, including surgical procedure, recovery from surgery, maintaining animal behavior, or for administering oral medications.

 

Propofol and etomidate are common general anesthesia drugs. Propofol is an agent for central nervous system relaxation and is used for a number of medical conditions such as anxiety, convulsions, restlessness, and tremors. Etomidate, or commonly known as a street drug, is an agent which is used to relieve pain and relax the muscles by blocking pain receptors in the brain. Etomidate acts as a powerful central nervous system (CNS) depressant, which makes it effective for multiple sclerosis, seizures, spinal cord injuries, substance abuse, and alcohol rehabilitation. Both propofol and etomidate are often used combined with analgesics to enhance the effectiveness of the drug.

Some common combinations include propofol with anti-emetics and anxiolytics, propofol with tricyclic antidepressants, and propofol with sedatives, all of which are designed to relax the patient. The combination of these drugs creates a drug cocktail that works effectively to reduce pain, calm the nervous system, prevent reflexive reactions, slow down the progression of depression, or slow down the loss of consciousness associated with some neurological disorders. This type of sedative is most often used to treat mild to moderate anxiety, epilepsy, cancer, migraine headaches, chronic pain, constipation, ringing in the ears, and sleep disorders. Propofol should never be administered alone and must always be administered with a dose of anti-anxiety medication. This is especially critical for those patients who take benzodiazepines, TCA, MAOI medications, MAOI multiple sclerosis drugs, antidepressants, MAOI beta blockers, tricyclic antidepressants, and tricyclic acid for treatment.

Byfavo, also known as Remimazolam, is another general anesthesia agent used for the temporary induction and maintenance of light or procedural sedation within patients lasting thirty minutes or more. It is a tranquilizer benzodiazepine agent, made from benzoyl peroxide. Its mechanism of action is via the inhibition of transmitter nerves which then decrease their activity. Because these nerve transmitters control anxiety and stress, the drug is said to augment the patient's mood and lessen his or her level of anxiety. It has been found effective in reducing anxiety levels up to several hundred points, with sedation becoming evident at about one hundred and twenty-five degrees. Various manufactures are focused on approval and launch of remimazolam. In November 2020, PAION AG, a specialty pharma company based in Germany, announced positive topline data from the pivotal remimazolam EU Phase III trial in general anesthesia. In the trial with 424 patients, remimazolam met both the primary and key secondary endpoints.

Global Food Stabilizer Market Continues to Grow Rapidly as Major Industry Leader Glanbia Nutritionals Completes Acquisition of Watson Inc., a provider of custom bakery ingredients

A stabilizer is an additive to food that helps to preserve its structure. Its primary application includes preventing oil, water emulsions from separating in products including salad dressing. These food stabilizers are a group of compounds that are responsible for adding viscosity to the mix. There are two types of food stabilizers namely artificial stabilizers and natural stabilizers. 

 

The multi-functionality of food stabilizers in different food & beverage products is expected to drive growth of the global food stabilizer market during the forecast period. The beverage stabilizers prevent degradation, sedimentation, and turbidity during beverage processing and also provide stability to beverages. For instance, Xanthan gum is used as a stabilizer, suspending agent, thickener, and emulsifier. Furthermore, stabilizers in food products help to increase the stability and thickness by helping foods remain in an emulsion and maintain physical characteristics. Many low-fat foods require stabilizers. Thus, these factors are expected to drive growth of the global food stabilizer market during the forecast period. Furthermore, the increase in demand for customized products is expected to boost the global food stabilizer market growth over the forecast period. Many products convenience food products or customized beverages require food stabilizers to extend the life of the product. Hence, such factors are expected to boost market growth in the near future. Moreover, rapid growth in demand for naturally-sourced ingredients is expected to accelerate the global food stabilizer market growth over the forecast period.

However, the stringent legal framework in the food & beverage industry combined with rising consumer demand for clean label products is expected to boost the global food stabilizer market growth over the forecast period. Besides, rapid growth of emerging markets and increasing investment for research and development activities to develop novel products can present lucrative growth opportunities in the global food stabilizer market during the forecast period. Among regions, Europe is expected to hold a dominant position in the global food stabilizer market during the forecast period. This is owing to the presence of a large food processing base across the region. Asia Pacific is expected to register a robust growth rate over the forecast period, owing to increasing disposable income and reside demand for processed food in emerging economies such as India and China.

Key players operating in the global food stabilizer market are Glanbia Nutritionals, Deosen Biochemical Ltd., E. I. DuPont de Nemours and Company, Archer Daniels Midland Company, Kerry Inc., Associated British Foods Plc., Hansen A/S, Koninklijke DSM N.V., Cargill, Inc., Holton Food Products, Chemelco International B.V., Tate & Lyle, and Palsgaard.

For instance, in February 2019, Glanbia Nutritionals, a subsidiary of Glanbia plc, acquired Watson Inc., a U.S.-based manufacturer of custom bakery ingredients.

Sheath material is a gaining popularity as a protective materials due to its excellent temperature strength, corrosion resistance properties

 

 

The term "sheath" is derived from a Latin word meaning "cover". In other words, it is an outer covering used for protection. In this case, protection is necessary against exposure to the elements as well as from accidental or intentional damage.

One of the advantages is that this material is generally stronger than comparable cloth or paper bags. It is also an attractive item that will enhance the appearance of any wardrobe there are various materials that can be used as a sheath material. Leather is one of the emerging materials. If properly cared for, sheaths made from leather can provide many years of use and enjoyment. The two primary types of leather sheath materials are leather and nylon. While leather is the most popular, nylon is growing in popularity. Both are relatively durable and resistant to corrosion but are somewhat heavier than leather. Nylon is often preferred over leather due to its economic nature. A nylon sheath costs about half the price of a comparable leather sheath.

The third most popular type of material is a polymer. It is similar to the appearance of rubber and has the same properties, including the ability to resist moisture. Some polymer materials may be coated with a moisture-resistance mechanism to increase this resistance, but it is not universal. The polymer is typically coated with an anti-corrosion agent to provide greater protection against moisture, but these coatings are not as universal as leather and nylon sheaths and should only be used where anti-corrosion is not a concern.

Steel is the most universal sheath material and the most common. It is resistant to abrasion, but not enough to overcome the inherent weaknesses of stainless steel.

Key Properties and Applications of Polyvinylidene Fluoride (PVDF); a Quick Overview

 

Polyvinylidene fluoride (PVDF), also known as polyvinylidene difluoride, is a semi-crystalline thermoplastic that belongs to the fluorine polymers group. PVDF is widely used in the form of membranes, coatings, pipes, sheets, and films in various end-use industries such as electrical and electronics, oil and gas, PV modules, automotive, chemical processing, building and construction, textiles, wires and cables, water treatment, etc. Polyvinylidene fluoride offers high corrosion resistance, weatherability, good adhesion, high thermal stability, and good chemical resistance. Cast parts, membranes, monofilament and drawn fibers, tubing, sheets, and rods are produced from polyvinylidene fluoride.

 

PVDF is a high-grade thermoplastic polymer produced by the chemical transformation of vinyl chloride into vinyl chloride terephthalate. Thermoplastic polymers are especially valuable in applications that require the use of high temperatures, since polyvinylidene fluoride contains the ability to resist extreme temperatures. PVDF also has excellent thermal conductivity, which makes it an ideal material for thermal insulation.

Polyvinylidene fluoride is widely used as insulation on wires due to its high heat resistance, high chemical resistance, low weight, and low thermal conductivity. Moreover, PVDF tubes, pipes, and hoses are used in the automobile fuel systems due to its properties such as chemical resistivity and impermeable nature. With the increasing use of polyvinylidene fluoride from various end-use industries, such as automotive, the demand for polyvinylidene fluoride is also increasing. Automakers sold more than 17 million vehicles in the U.S. for a fifth consecutive year in 2019.

PVDF is widely used in various chemical processing industries as metallic coatings for various applications such as pumps, membrane, filters, and heat exchangers. Polyvinylidene fluoride offers superior abrasion/chemical-resistance, corrosion barrier, thermal resistance, and high performance in harsh. Moreover, with the increasing use of polyvinylidene fluoride in the building and construction industry due to its characteristics, such as anti-skid, UV resistance, thermal resistance, wear resistance, chemical resistance, and abrasion resistance, the demand for PVDF is also increasing.

Global Turmeric Oleoresin Market is Gaining Significant Traction with Swiss Flavors Manufacturer Givaudan Completing Acquisition of Ungerer & Company, a U.S.-based flavors company

 

Turmeric Oleoresin, otherwise called Indian Gooseberry, is one of the curcumin powder used for the purpose of food and medicinal applications. Turmeric oleoresin has been proven to have various health benefits including being able to promote the immune system. In addition, the natural compound is also known to have antioxidant properties that help in the protection of the body from free radicals that can lead to cellular damage, cell mutation, lipid peridoxation, and cancer formation. In fact, researchers have even found out that this compound has cytotoxic activity towards human leukemia cells. Turmeric Oleoresin has been widely used as a food and medicine additive in India and other Asian countries where it is widely used for many medicinal purposes.

 

Increasing demand for natural food coloring agents is expected to drive growth of the global turmeric oleoresin market. Turmeric oleoresin is widely used in the baking industry as a flavoring and coloring agent due to its intense coloring properties. Consumers are increasingly demanding organic products with the inclusion of natural ingredients such as additives and food colorings. Key players in the market are focused on research and development activities, in order to launch novel products and cater to rising demand. For instance, in September 2019, Diana Food launched a new line of organic colors for food and beverages in Europe with EU compliance certification. Furthermore, in June 2020, DIC Lifetec Co. Ltd., a subsidiary of DIC Corporation, launched a liquid version of its Lineblue, a naturally-derived blue food coloring. Hence, such factors are expected to drive growth of the global turmeric oleoresin market. Furthermore, rising usage of oleoresin in dry mixes and margarine is expected to propel the global turmeric oleoresin market growth in the near future.

However, a stringent regulatory framework imposed by governing authorities is expected to hamper the global turmeric oleoresin market. Among regions, Europe is expected to witness significant growth in the global turmeric oleoresin market. This is owing to increasing demand for ethnic cuisines such as Mexican, Indian, and Thai in the region. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to the presence of the largest food and beverage industries across the region.

Key companies involved in the global turmeric oleoresin market are Nikita Extracts, Ozone Naturals, Ungerer & Company, Indo-World, Kancor Ingredients Limited, DDW The Color House, Asian Oleoresin Company, Synthite Industries Ltd, Vidya Herbs Pvt. Ltd., Givaudan, and Naturite Agro Products Ltd.

For instance, in November 2019, Givaudan, a Swiss manufacturer of flavors and fragrances, acquired Ungerer & Company, a U.S.-based flavors company.

High demand from construction and needle crafting application is augmenting the growth of the staple fiber market

 

Staple fiber refers to the fiber of short length and can be of any fiber composition. A continuous fiber like natural or artificial silk is called staple fiber and not short-staple fibers. They are used in baby clothing, adult clothing, towels, socks, caps, etc. Some manufacturers use short-staple fibers in making children's clothing and men's suits because of their softness. Short staple fibers are also used in making draperies and rugs as they do not absorb moisture well. They are made of needles and yarns of the same length. There are some producers who make fibers of longer length from wool and cotton. This can be produced easily, as there is less work involved.

 

Increasing demand for the product from clothing construction, needle crafting, rug-making, and weaving industries is primarily fueling of the staple fibers market growth. The yarns of the product are suitable for producing heavy-use objects such as coats, rugs, wrap threads, and blankets. Growing demand for carpets due to the increasing number of houses is again driving the growth of the market. This is also attributed to the increasing population around the globe. The decrease in temperature level is boosting demand for blankets during winters and also in colder areas. This has further boosted the growth of the market. Furthermore, the growing demand for cost-effective synthetic fibers from developing countries is further projected to propel the growth of the Staple fibers market.

The Asia Pacific is projected to gain significant growth over the forecast period and this is attributed to the improving economic conditions coupled with the rise in the number of manufacturing industries. According to the India Brand Equity Foundation, India exported 34% of the world's polyester staple fibers ($24 million) and China exported 22% ($16.4 million) of the world's polyester staple fibers. These two countries are accounted for as the major exporters of polyester staple fibers.

Key Developments:

1. In March 2019, Beaulieu Fibers International (BFI), a European polyolefin fiber supplier has exhibited at the IDEA 2019 show in Miami, FL, as an ‘all solution provider’ for polyolefin carded nonwovens in personal care and hygiene, geotextiles, automotive, floor coverings, and filtration applications.

2. In February 2020, Eastman, the producer of sustainably sourced Naia™ cellulosic filament yarn, announces the expansion of its Naia™ fiber portfolio at Première Vision-Paris (PV), the international fashion and textile exposition

3. In October 2020, China's Zhengzhou commodity exchange (ZCE) launched its polyester staple futures.

4. In June 2020, Turkey announced the launch of a safeguard investigation on staple fibers of polyestersa

High demand for preservative and additive from wide range of industries is expected to provide room for Sodium metabisulphite market growth

 

Sodium metabisulphite has been used as an antibacterial agent in several pharmaceutical formulations. It is extensively used as a general food preserver and food additive. Sodium metabisulphite can also be used to disinfect surgical and other sites where it is needed. It is very effective against the growth of microorganisms resistant to commonly used disinfectants. It has been found that the use of sodium metabisulphite in combination with normal bio purification methods is very efficient in removing microorganisms resistant to sulfate-based bio purification processes. 

 

High demand for sodium metabisulphite from the cosmetic and personal care industry where it is used as a preservative and antioxidants is fueling the growth of the sodium metabisulphite market. The increasing number of working women coupled with the improving standard of living of the consumers is again driving the growth of the market. Moreover, increasing consumption of beer and wine as it is also used in the manufacturing of wine and beer is further anticipated to augment the growth of the sodium metabisulphite market. It sterilizes alcoholic beverages and acts as an antioxidant in the manufacturing process of beer brewing and wine fermentation. According to Alcohol.org, in 2017 in the United States alone, an estimated 65 billion 12 oz. beers were consumed, along with over 4 billion bottles of wine.

Moreover, the product is also used across other end-user industries such as chemical & pharma, leather industry, textile industry, pulp & paper, and photographic & film

The Asia Pacific is projected to gain significant growth over the forecast period and this is attributed to the increasing demand for sodium metabisulphite from the textile industry. The expansion of the textile industry is contributing to the regional growth of the sodium metabisulphite market. According to the India Brand Equity Foundation, India’s textiles industry contributed 13% of the industrial production in FY20. It contributed 2.3% to the GDP of India and employed more than 45 million people in FY20. The sector contributed 12% to India’s export earnings in FY20. Also, high demand for the product from the footwear industry in the region is further projected to foster the growth of the sodium metabisulphite market

Key Players:

1. BASF SE

2. The Dow Chemical Company

3. Solvay

4. Aditya Birla Chemicals

5. Shandong Kailong Chemical Technology Development Co., Ltd.

Increasing Prevalence of Chronic Disorders and Initiatives to Develop Flying Ambulance for Medical Emergency Use to Augment Growth of Air Ambulance Services Market

 

Increasing prevalence of chronic disorders is expected to propel growth of the global air ambulance services market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

 

Emergence of Covid-19 is expected to propel growth of the global air ambulance services market. For instance, globally, as of 6:51pm CET, 3 January 2021, there have been 83,322,449 confirmed cases of COVID-19, including 1,831,412 deaths, reported to the World Health Organization.

High cost of air ambulance services and the relative low adoption of these services in emerging economies compared to developed countries is expected to hinder growth of the global air ambulance services market.

Among regions, North America is expected to witness significant growth in the global air ambulance services market, owing to launch of new services. For instance, in September 2020, WellSpan Health, an integrated health system in the U.S., and Air Methods, a leading air medical service in the U.S., jointly launched a new medical helicopter service to improve access to emergency air transport services for the most critically injured or sick patients.

Read more@https://app.bitly.com/Bkcf90dKDvV/bitlinks/2Me7HEI

Global Chlorine Market is expected to witness robust growth as Spanish Chemicals Giant Ercros S.A. Completed Expansion of its chlorine-caustic soda plant in Vila-Seca I factory

 

Chlorine is the most common oxidizing agent used in public water supplies. With the US Public Health Service (PHS) recommending that the public water systems across the United States be tested for this hazardous chemical, the number of people who are aware of the hazards posed by exposure to chlorination has dramatically increased. The International Agency for Research on Cancer (IARC) is responsible for defining the human cancer risk associated with exposure to this compound. Because of this exposure, the role of chlorination in controlling water quality should be seriously considered.

 

Rapid growth of the chemical industry in both developed and emerging economies is expected to drive growth of the global chlorine market. The chemicals sector has witnessed massive growth with increasing demand for various chemical end-use industries. According to the India Brand Equity Foundation (IBEF), the Indian chemicals sector is expected to reach US$ 300 billion in 2025, registering an annual growth rate of around 15-20%. According to the same source, organic and inorganic chemicals export accounted for US$ 13.85 billion from April to November 2020. Chlorine has diverse applications, typically being used as a disinfectant. It is used to treat drinking water and swimming pool water. Besides, it is used to make numerous consumer products such as paints, paper, textiles, and insecticides. Hence, these factors are expected to drive growth of the global chlorine market. Furthermore, increasing demand for PVC from the construction sector is expected to propel the global chlorine market growth in the near future.

However, negative environmental impacts and energy-intensive operations are expected to restrain growth of the global chlorine market. Rapid developments in emerging markets such as China, India, and Japan can present lucrative growth opportunities for industry players in the near future. Among regions, Asia Pacific is expected to witness significant growth in the global chlorine market. This is owing to increasing demand for PVC in automotive, construction, and packaging sectors across the region. Besides, rampant growth of chemicals sector is expected to boost the regional market growth. Furthermore, North America is expected to register a robust growth rate, owing to growing shift from mercury-based production to membrane-based technology in the region.

Key companies involved in the global chlorine market are Nouryon, Tosoh Corporation, BASF SE, Tata Chemicals Ltd., Ercros S.A., OLIN Corporation, Formosa Plastics Corporation, Occidental Petroleum Corporation (OXY), FMC Corporation, and Hanwha Chemical Corporation.

For instance, in October 2019, Ercros S.A., a Spanish chemicals company, expanded its chlorine-caustic soda plant in Vila-Seca I factory with a new electrolyzer.

Rising Incidence of Cancer to Augment the Cancer Biomarkers Market Growth

 

Cancer biomarkers are tools used to detect the disease process and monitor the response to therapy in cancer patients. A cancer biomarker refers to any substance or procedure that is characteristic of the existence of cancer in the human body. A biomarker can be a substance secreted by the tumor itself or a general biological response of the human body to the existence of cancer. These substances include serum creatinine, tumor antigens, cytokines, free radicals, chemo markers, DNA methylation, and receptor antigens.

Many cancer biomarkers currently being tested in clinical trials to assess their activity on various cancers. Although these tests are still at an early stage, many exciting results are being seen with each passing day. Moreover, continued advances in cancer diagnosis include the use of molecular biomarkers as part of routine clinical trials. Molecular alterations used for cancer diagnosis involves application of DNA, RNA, microRNAs, and proteins.

Market Dynamics:

Increasing incidence/prevalence of cancer worldwide is expected to fuel the growth of the cancer biomarkers market. For instance, according to the World Health Organization (WHO), cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018.

Moreover, continuous advancements in cancer diagnosis are also expected to augment the growth of the cancer biomarkers market. For instance, in January 2021, biomedical engineers at Duke University devised an algorithm to find new biomarkers and better understand how numerous cancers affect the human body.

Increasing number of collaborations and partnerships and increasing research and development activities are expected to propel the growth of the cancer biomarkers market. For instance, in January 2021, Indian Institute of Technology (Guwahati) signed MoU with North East Cancer Hospital and Research Institute (NECHRI), Assam (India) to identify novel biomarkers for cancer diagnosis, prognosis, therapy, and recurrence.

Increasing use of cancer biomarkers in drug discovery and development and increasing research on cancer biomarkers is also expected to aid the market growth.

North America is expected to witness substantial growth in the cancer biomarkers market due to increasing prevalence of cancer in the region. For instance, according to American Cancer Society, there were likely to be approximately 1,806,590 new cancer cases and 606,520 deaths in the United States in 2020.

Competitive Analysis:

Major players operating in the cancer biomarkers market are Thermo Fisher Scientific Inc., Qiagen N.V., Dickinson and Company, BioMerieux S.A., Merck & Co., Becton, Abbott Laboratories, Bio-Rad Laboratories, and Bard1 Life Sciences Limited.

https://www.coherentmarketinsights.com/market-insight/cancer-biomarkers-market-175

Increasing Prevalence of Peripheral Vascular Disease (PVD) to Augment the Blood Flow Measurement Devices Market Growth

 

Blood flow measurement devices help in understanding the nature of blood flow such that the volume of blood supplied to various organs and abnormal changes in blood flow velocity. On the basis of products, these devices are divided into electromagnetic, laser Doppler, and ultrasonic Doppler blood flow meters.

 Market Dynamics:

Increasing prevalence of peripheral vascular disease (PVD) combined with growing geriatric population is expected to augment the blood flow measurement devices market growth. For instance, around 6.5 million people age 40 and older in the United States have PVD, according to the Centers for Disease Control and Prevention (CDC).

Moreover, increasing research and development activities, as well as continuous advancements in the blood flow measurement devices are expected to propel the growth of the blood flow measurement devices market. For instance, in Jan. 2021, Valencell announced the development of an upgraded biometric blood pressure measuring technology for healthcare wearables that does not require calibration or a worn cuff.

Increasing prevalence of cardiovascular diseases and increasing adoption of innovative devices by the major players are also expected to fuel the growth of the market. For instance, in Jan. 2021, Sky Medical Technology announced that Luton and Dunstable University Hospital are the first NHS hospital in the South East to deploy the innovative geko device for VTE prevention in immobile acute stroke patients who cannot be prescribed the current standard of care.

Increasing clinical applications of blood flow measurement devices are expected to offer lucrative growth opportunities for players the market.

However, high cost of devices, stringent regulations, slow approval processes, and high investment for R&D and clinical trials are some of the factors expected to restrain the blood flow measurement devices market growth.

Competitive Analysis:

Key players operating in the blood flow measurement devices market are Compumedics Ltd., Carolina Medical Plc., Ace Medicals, Flowtronics Inc., Elcat GmBH, Cook Medical, D E Hokanson Inc., AKW Medicals Inc., Biomedix Inc, Medtronics, Transonic Systems, Perimed AB, Moor Instruments Ltd., Medistim ASA, GF Health Products, Deltex Medical Ltd., Arjo, Cook Medical Inc., Compumedics Ltd., and Atys Medical.

Key players in the market are focused on launch and approval of new devices to enhance their market presence or to strengthen their product portfolio. For instance, in January 2020, Cook Medical received FDA (Food and Drug Administration) authorization to market new EchoTip Insight Portosystemic Pressure Gradient Measurement System, an endoscopic ultrasound device to measure portal hypertension, in the United States.